Idiopathic Parkinson's disease (IPD) represents a common neurodegenerative disorder. An estimated 2% of the U.S. population, age 65 and older, develops IPD. The number of IPD patients will certainly increase over the next several decades as the baby-boomers gradually step into this high-risk age group, concomitant with the increase in the average life expectancy. While many studies have suggested that industrial chemicals and pesticides may underlie IPD, its etiology remains elusive. Among the toxic metals, the relationship between manganese intoxication and IPD has long been recognized. The neurological signs of manganism have received close attention because they resemble several clinical disorders collectively described as extrapyramidal motor system dysfunction, and in particular, IPD and dystonia. However, distinct dissimilarities between IPD and manganism are well established, and it remains to be determined whether Mn plays an etiologic role in IPD. It is particularly noteworthy that as a result of a recent court decision, methylcyclopentadienyl Mn tricarbonyl (MMT) is presently available in the United States and Canada for use in fuel, replacing lead as an antiknock additive. The impact of potential long-term exposure to low levels of MMT combustion products that may be present in emissions from automobiles has yet to be fully evaluated. Nevertheless, it should be pointed out that recent studies with various environmental modeling approaches in the Montreal metropolitan (where MMT has been used for more than 10 years) suggest that airborne Mn levels were quite similar to those in areas where MMT was not used. These studies also show that Mn is emitted from the tail pipe of motor vehicles primarily as a mixture of manganese phosphate and manganese sulfate. This brief review characterizes the Mn speciation in the blood and the transport kinetics of Mn into the central nervous system, a critical step in the accumulation of Mn within the brain, outlines the potential susceptibility of selected populations (e.g., iron-deficient) to Mn exposure, and addresses future research needs for Mn.
Manganese is an abundant metal. It is ubiquitous in the environment, and it occurs in water, soil, air, and food. Its essentiality is critical throughout the life span of the mammalian organism because it serves as a necessary constituent of metalloproteins, including the mitochondrial enzymes, superoxide dismutase (SOD) and pyruvate carboxylase, and the astrocyte-specific enzyme, glutamine synthetase (GS) (1, 2) . In nonoccupationally exposed individuals, the major route of exposure to Mn is via food. Average intake of Mn is between 2 and 9 mg/day (for an average 70-kg person). Avocados, blueberries, nuts and seeds, seaweed, egg yolks, whole grains, legumes, dried peas, and green leafy vegetables are particularly rich in Mn as is tea. Substantial tea intake in the diet accounts for the significantly greater daily intake of Mn in Britain than in the United States (8.8 and 2.5-4 mg Mn/day, respectively). The predominant route of exposure to Mn in occupational settings is by inhalation. Although only a small fraction of Mn accumulates in the brain, the latter is critically affected both by deficiency and excess of Mn. Mn readily crosses the blood-brain barrier (BBB) in the developing fetus, neonate, and the mature mammal (3, 4) . The brain normally contains only a small amount of Mn (5) , and both deficiency and excess of Mn critically affect it. Seizure activity, a hallmark of Mn deficiency, is believed to result from decreased Mn-superoxide dismutase (Mn-SOD) and GS activities (6) , whereas excessive exposure to Mn is associated with an irreversible central nervous system (CNS) disorder characterized by prominent psychological and neurological disturbances. Idiopathic Parkinson's disease (IPD) represents a common neurodegenerative disorder. An estimated 2% of the U.S. population, age 65 and older, develops IPD. The number of IPD patients will increase over the next century as the baby-boomers gradually step into this high-risk age group, concomitant with the increase in the average life expectancy. While the symptoms of IPD are clearly distinct from those in manganism (see below), given the many similarities between the two disorders, the role of long-term exposure to Mn in IPD should not be immediately dismissed.
Initial symptoms associated with manganism are of psychiatric nature, and are clinically defined as locura manganica. These symptoms closely resemble those encountered in schizophrenics, and they include compulsive or violent behavior, emotional instability, and hallucinations. Neurological manifestations usually begin shortly (1-2 months after the first symptoms) after the appearance of those psychiatric symptoms. The neurological signs include progressive bradykinesia, dystonia, and disturbance of gait. The facial expression is somewhat fixed, and speech difficulty is frequently observed. Progressively, the patients develop slurring and stuttering speech with diminished volume and their voices become monotonous and sink to a whisper. The speech is slow and irregular, at times with a stammer. The clinical picture closely resembles several other clinical disorders collectively described as extrapyramidal motor system dysfunction and, in particular, Parkinson's disease and dystonia (7) (8) (9) . At the cellular level, this condition is associated with increased Mn concentrations, primarily in those CNS areas known to contain high concentrations of nonheme iron. These areas comprise the caudate-putamen, globus pallidus, substantia nigra, and subthalamic nuclei (10, 11) . Nevertheless, unlike in IPD, Mn intoxication is associated with preservation of the nigrostriatal dopaminergic pathway despite clinical evidence of parkinsonian-like deficits (9) . Damage to output pathways downstream to the nigrostriatal dopaminergic pathway (globus pallidus) has been implicated as a potential cause for the parkinsonism-like syndrome associated with chronic low-level Mn exposure (9) . Furthermore, in manganism Lewy bodies are seldom found in the substantia nigra, but they are usually found in patients with Parkinson's disease (So.
There are a limited number of studies that address the neurological deficits of Mn exposure in children. Two studies (12, 13) indicate that children who ingested Mn in the drinking water (. 0.241 mg/L) for a minimum of 3 years performed more poorly in school as M.ASCHNER measured by mastery in Chinese, mathematics performance, and in their overall grade average (compared with nonexposed students). The Mn-exposed children also performed more poorly on a battery of neurobehavioral tests. Mn exposure levels in these students were determined by hair analysis. It is noteworthy that no reference was made in the study (13) The CNS distribution of Tf receptors in relationship to Mn accumulation is noteworthy. The thalamic nuclei, the pallidum, and the substantia nigra contain the highest Mn concentrations (7) . Although the areas with dense Tf distribution (25) do not correspond to the distribution of Mn (or Fe), the fact that Mn-accumulating areas are efferent to areas of high Tf receptor density suggests that these sites may accumulate Mn via axonal transport (26) . For example, the nucleus accumbens and the caudate-putamen-two areas that are abundantly rich in Tf receptors-provide efferent fibers to the Mn-rich areas of the ventral-pallidum, the globus pallidus, and the substantia nigra (27, 28) .
A limited number of studies addressed the transport kinetics of Mn into the CNS. The studies are largely derived from animal models (particularly rodents). Although the rodent (specifically the rat) does not represent an optimal animal model to study the mechanisms of Mn-induced neurotoxicity, the distinction between species is not made in this review, since no evidence exists to substantiate differential transport systems for Mn in the rodent and the primate. Collectively, transport studies suggest that MnCI2 enters the brain from the blood either across the cerebral capillaries and/or the cerebrospinal fluid (CSF). At normal plasma concentrations, Mn enters the CNS primarily across the capillary endothelium, whereas at high plasma concentrations, transport across the choroid plexus predominates (14, (29) (30) (31) (32) (33) .
Mn accumulates in the olfactory bulb and tubercle as well as cerebral cortex, hypothalamus, striatum, and hippocampus after intranasal injection into the nostril (34-36) .
Thus, when inhaled, Mn may be absorbed via the olfactory pathway. The relative amounts absorbed and the significance of this pathway for brain Mn accumulation are not accurately defined.
The impact of potential long-term exposure to low levels of MMT combustion products that may be present in emissions from automobiles has yet to be fully evaluated. Using various environmental modeling approaches, it was estimated that air levels of Mn in most urban areas in the United States would increase < 0.02 ,ug/m3 if MMT were used in all unleaded gasoline (37) . A probability-based study involving over 900 personal exposure samples in Montreal (where MMT has been used for more than 10 years) confirmed that exposures to airborne Mn < 2.5 pm in aerodynamic diameter in the general population are quite low (0.008 pg/m3-median), suggesting that airborne Mn levels in Montreal were quite similar to those in areas where MMT was not used (37) . These studies also show that Mn is emitted from the tailpipe of motor vehicles primarily as a mixture of manganese phosphate and manganese sulfate and, to a lesser extent, oxides [e.g., manganese tetroxide (Mn304)] (51). Moreover, isolated particles consist of manganese, oxygen, phosphorous, and sulfur and indicate that manganese phosphate is the main constituent of the residual particles (38) .
The differential distribution in rats exposed to two forms of manganese, MnCl2 and MnO2, administered by intratracheal injection, gavage, or intraperitoneal injection were studied by Roels et al. (39) . When administered as MnO2 by intratracheal injection (mimicking the inhalation route), the distribution of Mn in the CNS was similar to that of MnCl2, accumulating preferentially in striatum, cortex, and cerebellum. However, Mn (3, 4) . In vivo, intravenous administration of ferric hydroxide-dextran complex significantly inhibits the net uptake of Mn in the CNS, and high Fe food intake reduces the concentration of Mn in the CNS (3,42).
Chemically and biochemically, Mn shares numerous similarities with Fe. For example: a) both metals are transition elements adjacent to each other in the Periodic Table; b) both carry similar valence charges (2+ and 3+) in physiological conditions; c) both have similar ionic radius; d) both strongly bind Tf (3, 14, 22) , and e) intracellularly, both preferentially accumulate in mitochondria (43, 44 
